EP Patent

EP0245518A1 — Isoflavone derivatives, salts thereof, and oncostatic and immunosuppressive agents

Assigned to Yamanouchi Pharmaceutical Co Ltd · Expires 1987-11-19 · 38y expired

What this patent protects

Novel isoflavone derivatives represented by general formula (I) and salts thereof having oncostatic and immunosupressive effects, and novel oncostatic and immunosuppressive agents.

USPTO Abstract

Novel isoflavone derivatives represented by general formula (I) and salts thereof having oncostatic and immunosupressive effects, and novel oncostatic and immunosuppressive agents.

Drugs covered by this patent

Patent Metadata

Patent number
EP0245518A1
Jurisdiction
EP
Classification
—
Expires
1987-11-19
Drug substance claim
No
Drug product claim
No
Assignee
Yamanouchi Pharmaceutical Co Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.